Clinical trials: Secondary Malignant Neoplasm of Spine
Secondary Malignant Neoplasm of Spine
Involved Versus Elective Target SSRS for Spinal Metastases
The spine is a common metastatic site for malignancy and it can lead to serious and devastating events, including pain, neurological dysfunction, and reduction in quality of life.
- Trial name
- NCT04033536
- Testing
- Involved Target Stereotacic Spine Radiosurgery, Elective Target Stereotacic Spine Radiosurgery
- Where
- Taiwan
- Volunteers
- 114 people
- Sponsor
- National Taiwan University Hospital
Secondary Malignant Neoplasm of Spine
Single Versus Multiple Fractionated SSRS for Spinal Metastases
The investigators proposed this randomized study to determine the feasibility of delivering single-fraction 16-Gy versus 3-fraction 24-Gy toward spine metastatic lesion and to evaluate their toxicity profiles.
- Trial name
- NCT02608866
- Testing
- SF-SSRS, MF-SSRS
- Where
- Taiwan
- Volunteers
- 68 people
- Sponsor
- National Taiwan University Hospital